MBP 3.23% 3.0¢ metabolic pharmaceuticals limited

hold tight guys-see extract:

  1. 22,691 Posts.

    "Their “Intermediate Term Target Price Estimates” are in the range $2.29 for the pessimistic scenario
    through to $4.67 for the optimistic scenario.

    Metabolic believes this report will be released into
    Cohen Independent Research Group’s distribution list on commencement of business after the July 4
    long weekend in the U.S".

    This and next week could be interesting IMHO.

    Info on MBP:

    Readers, please do your own research and you decide if and when to buy, hold or sell any stocks.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.